TY  - CHAP
M1  - Book, Section
TI  - The Goodman & Gilman Year in Review: New and Noteworthy FDA Approvals
A1  - Murri, PharmD, MBA, Nelda
A2  - Brunton, Laurence L.
A2  - Chabner, Bruce A.
A2  - Knollmann, Björn C.
Y1  - 2015
N1  - 
T2  - Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 12e
AB  - In  2016  the  U.S.  Food  and  Drug  Administration  (FDA)  approved  22  new  drugs  and  granted  32  noteworthy  biologic  licenses.  Among  the  22  new  drugs  are:  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2021/01/21
UR  - accessbiomedicalscience.mhmedical.com/content.aspx?aid=1142353981
ER  -